Evidence map›Paper›PMID 40938701›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

Posttranscriptional control of the B cell receptor by HuR is essential for innate B cell maintenance and function.

Dunja Capitan-Sobrino, Mailys Mouysset, Orlane Maloudi, Yann Aubert, Ines C Osma-Garcia, Trang-My M Nguyen, Greta Dunga, Maia Nestor-Martin, Virginie Mieulet, Manuel D Diaz-Muñoz

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Posttranscriptional control of the B cell receptor by HuR is essential for innate B cell maintenance and function.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Dunja Capitan-SobrinoToulouse Institute for Infectious and Inflammatory Diseases (INFINITY), Inserm UMR1291, CNRS UMR5051, University of Toulouse, Centre Hospitalier Universitaire (CHU) de Toulouse - Purpan, Toulouse 31024, France.
Mailys MouyssetToulouse Institute for Infectious and Inflammatory Diseases (INFINITY), Inserm UMR1291, CNRS UMR5051, University of Toulouse, Centre Hospitalier Universitaire (CHU) de Toulouse - Purpan, Toulouse 31024, France.
Orlane MaloudiToulouse Institute for Infectious and Inflammatory Diseases (INFINITY), Inserm UMR1291, CNRS UMR5051, University of Toulouse, Centre Hospitalier Universitaire (CHU) de Toulouse - Purpan, Toulouse 31024, France.
Yann AubertToulouse Institute for Infectious and Inflammatory Diseases (INFINITY), Inserm UMR1291, CNRS UMR5051, University of Toulouse, Centre Hospitalier Universitaire (CHU) de Toulouse - Purpan, Toulouse 31024, France.ORCID 0000-0002-9769-6133
Ines C Osma-GarciaToulouse Institute for Infectious and Inflammatory Diseases (INFINITY), Inserm UMR1291, CNRS UMR5051, University of Toulouse, Centre Hospitalier Universitaire (CHU) de Toulouse - Purpan, Toulouse 31024, France.
Trang-My M NguyenToulouse Institute for Infectious and Inflammatory Diseases (INFINITY), Inserm UMR1291, CNRS UMR5051, University of Toulouse, Centre Hospitalier Universitaire (CHU) de Toulouse - Purpan, Toulouse 31024, France.
Greta DungaToulouse Institute for Infectious and Inflammatory Diseases (INFINITY), Inserm UMR1291, CNRS UMR5051, University of Toulouse, Centre Hospitalier Universitaire (CHU) de Toulouse - Purpan, Toulouse 31024, France.
Maia Nestor-MartinToulouse Institute for Infectious and Inflammatory Diseases (INFINITY), Inserm UMR1291, CNRS UMR5051, University of Toulouse, Centre Hospitalier Universitaire (CHU) de Toulouse - Purpan, Toulouse 31024, France.ORCID 0009-0001-6422-2724
Virginie MieuletToulouse Institute for Infectious and Inflammatory Diseases (INFINITY), Inserm UMR1291, CNRS UMR5051, University of Toulouse, Centre Hospitalier Universitaire (CHU) de Toulouse - Purpan, Toulouse 31024, France.
Manuel D Diaz-MuñozToulouse Institute for Infectious and Inflammatory Diseases (INFINITY), Inserm UMR1291, CNRS UMR5051, University of Toulouse, Centre Hospitalier Universitaire (CHU) de Toulouse - Purpan, Toulouse 31024, France.ORCID 0000-0002-9227-7474

Funding

Agence Nationale de la Recherche (ANR) ANR-20-CE15-0007Agence Nationale de la Recherche (ANR) ANR-22-CE15-0013Agence Nationale de la Recherche (ANR) ANR-24-CE15-5291ATIP-Avenir, Plan Cancer program C18003BSBoehringer Ingelheim Fonds (BIF) N/AFondation pour l'Aide à la Recherche sur la Sclérose en Plaques (ARSEP) R19201BBFondation pour la Recherche Médicale (FRM) EQU202303016269Fondation pour la Recherche Médicale (FRM) FDT202304016365
6 · The paper itself

Abstract

Innate B-1 cells constitute a self-maintained layer of defense for early detection of bacteria, clearance of apoptotic cell debris, and removal of autoantigens driving autoimmunity. B-1 cells are originated from fetal tissues, but, as opposed to B-2 cells, the molecular mechanisms behind their development and homeostatic maintenance remain largely unknown. Here, we demonstrate that posttranscriptional regulation by the RNA binding protein HuR is essential for the homeostatic self-replenishment of innate B-1a cells, the expansion of B-1 cell clones targeting self-antigens, and the production of natural autoantibodies. HuR KO B-1 cells fail to express the high levels of surface B-cell receptor (BCR), TACI, and BAFFR required for tonic signaling and cell survival. At the molecular level, HuR promotes the translation of messenger RNAs encoding the IgM heavy chain and modules, in a direct or indirect manner, the expression of TACI and BAFFR. In summary, we reveal the need for posttranscriptional regulation in BCR expression, tonic signaling, and homeostatic maintenance of functional innate B-1 cells.

Indexed as

B-LymphocytesELAV-Like Protein 1Immunity, InnateReceptors, Antigen, B-CellRNA Processing, Post-TranscriptionalAnimalsB-Cell Activation Factor ReceptorMiceMice, Inbred C57BLMice, KnockoutSignal TransductionTransmembrane Activator and CAML Interactor ProteinB-Cell Activation Factor ReceptorElavl1 protein, mouseELAV-Like Protein 1Receptors, Antigen, B-CellTnfrsf13b protein, mouseTransmembrane Activator and CAML Interactor ProteinBCR expression and signalingdevelopment and functionHuRinnate B-1 cellsposttranscriptional gene regulation

Identifiers

PMID40938701
PMCPMC12452923

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.